Literature DB >> 16495806

Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence.

Sylvain Perruche1, Aliette Marandin, François Kleinclauss, Régis Angonin, Stéphanie Fresnay, Marie Hélène Baron, Pierre Tiberghien, Philippe Saas.   

Abstract

BACKGROUND: Use of a reduced-intensity conditioning regimen before an allogeneic hematopoietic cell transplantation is frequently associated with an early state of mixed hematopoietic chimerism. Such a coexistence of both host and donor hematopoietic cells may influence posttransplant alloreactivity and may affect the occurrence and severity of acute and chronic graft-versus-host disease (GVHD) as well as the intensity of the graft-versus-leukemia effect. Here we evaluated the relation between chimerism state after reduced-intensity conditioning transplantation (RICT), autoantibody production, and chronic GVHD (cGVHD)-related pathology.
METHODS: Chimerism state, circulating anticardiolipin, and antidouble stranded DNA autoantibody (Ab) titers as well as occurrence of cGVHD-like lesions were investigated in a murine RICT model.
RESULTS: We observed a novel association between mixed chimerism state, high levels of pathogenic IgG autoantibodies, and subsequent development of cGVHD-like lesions. Furthermore, we found that the persistence of host B cells, but not dendritic cell origin or subset, was a factor associated with the appearance of cGVHD-like lesions. The implication of host B cells was confirmed by a host origin of autoantibodies.
CONCLUSION: Recipient B cell persistence may contribute to the frequency and/or severity of cGVHD after RICT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495806      PMCID: PMC3414374          DOI: 10.1097/01.tp.0000183878.53367.77

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  48 in total

1.  Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential.

Authors:  Pilar Martín; Gloria Martínez Del Hoyo; Fabienne Anjuère; Cristina Fernández Arias; Héctor Hernández Vargas; Africa Fernández-L; Verónica Parrillas; Carlos Ardavín
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

2.  Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies.

Authors:  P Kier; E Penner; S Bakos; P Kalhs; K Lechner; B Volc-Platzer; J Wesierska-Gadek; G Sauermann; H Gadner; W Emminger-Schmidmeier
Journal:  Bone Marrow Transplant       Date:  1990-08       Impact factor: 5.483

Review 3.  Graft-versus-host disease.

Authors:  J L Ferrara; H J Deeg
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

4.  Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients.

Authors:  A M Rouquette-Gally; D Boyeldieu; A C Prost; E Gluckman
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

5.  Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.

Authors:  L M Griffith; J P McCoy; C D Bolan; D F Stroncek; A C Pickett; G F Linton; A Lundqvist; R Srinivasan; S F Leitman; R W Childs
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

6.  Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.

Authors:  M Sykes; A Eisenthal; D H Sachs
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

7.  Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D Stephany; D H Sachs
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

9.  A single-platform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow transplantation.

Authors:  Sylvain Perruche; François Kleinclauss; Agnès Lienard; Eric Robinet; Pierre Tiberghien; Philippe Saas
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

10.  Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease.

Authors:  Marijke R Canninga-van Dijk; Hanneke M van der Straaten; Rob Fijnheer; Cornelus J Sanders; Jan G van den Tweel; Leo F Verdonck
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more
  9 in total

Review 1.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

2.  IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.

Authors:  Manish J Butte; Charles Haines; Francisco A Bonilla; Jennifer Puck
Journal:  Clin Immunol       Date:  2007-09-12       Impact factor: 3.969

Review 3.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

Review 4.  Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.

Authors:  Chao Hong; Rong Jin; Xiaoqiu Dai; Xiaoming Gao
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

5.  Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Athanassios C Tsamandas; Christina Kalogeropoulou; Alexandra Kazantzi; Chaido Sirinian; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Rheumatology (Oxford)       Date:  2009-05-15       Impact factor: 7.580

6.  A pediatric case of systemic lupus erythematosus developed 10 years after cord blood transplantation for juvenile myelomonocytic leukemia.

Authors:  Masayuki Nagasawa; Yuki Aoki
Journal:  Case Rep Transplant       Date:  2012-12-10

Review 7.  The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.

Authors:  Margherita Boieri; Pranali Shah; Ralf Dressel; Marit Inngjerdingen
Journal:  Front Immunol       Date:  2016-08-30       Impact factor: 7.561

8.  Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Kaibo Yang; Yanqiu Chen; Hanzhou Qi; Yiling Ye; Zhiping Fan; Fen Huang; Haiyan Zhang; Yuan Suo; Qifa Liu; Hua Jin
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

Review 9.  Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.

Authors:  Pusen Wang; Zhongyi Jiang; Chunguang Wang; Xueni Liu; Hao Li; Dingyin Xu; Lin Zhong
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.